32 studies found for:    Open Studies | "Hair Diseases"
Show Display Options
Rank Status Study
1 Unknown  Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
Condition: Alopecia
Intervention: Drug: AS101
2 Recruiting Minoxidil Response Testing in Males With Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention: Drug: 5% minoxidil topical foam
3 Recruiting Excimer Light for Alopecia Areata
Condition: Alopecia Areata
Intervention: Procedure: UVB excimer light
4 Unknown  Enhanced Safety Laser Hair Removal System
Conditions: Hirsutism;   Hypertrichosis
Intervention: Device: Peterio
5 Unknown  Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
Condition: Alopecia Areata
Intervention: Drug: Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units
6 Recruiting Efficacy of Nutrition Supplement for Treatment of Men With Hair Loss
Condition: Androgenetic Alopecia
Interventions: Dietary Supplement: HCap Formula;   Dietary Supplement: Placebo
7 Not yet recruiting Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Device: PRGF-Endoret;   Other: Saline Solution
8 Unknown  Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata
Condition: Alopecia Areata
Interventions: Device: Subcutaneous injection luer syringe;   Device: DERMOJET (a syringe without a needle)
9 Recruiting A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
Condition: Androgenetic Alopecia
Interventions: Drug: CB-03-01 solution;   Drug: Minoxidil Solution 5%;   Drug: Placebo solution
10 Recruiting Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Topical latanoprost 0.005%;   Drug: Topical betamethasone 0.05%
11 Unknown  Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss
Condition: Female Pattern Hair Loss
Interventions: Drug: Spironolactone;   Drug: Minoxidil
12 Recruiting Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention: Device: topical 5% Minoxidil (Microneedling)
13 Recruiting 7% Lidocaine/7% Tetracaine Cream Versus 2,5% Lidocaine / 2,5% Prilocaine Cream
Conditions: Tattoo;   Acne Keloidalis Nuchae
Interventions: Drug: 2,5% lidocaine / 2,5% prilocaine cream;   Drug: 7% lidocaine / 7% tetracaine cream;   Device: Neodymium-doped yttrium aluminium garnet (Nd:Yag) laser;   Device: Q-switched nd Yag laser
14 Unknown  Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Condition: Alopecia
Interventions: Drug: 7% (w/v) Tempol alcohol-based gel (MTS-01);   Drug: alcohol-based gel
15 Recruiting Intralesional Steroids in the Treatment of Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Triamcinolone 2.5 mg/ml;   Drug: Triamcinolone 5 mg/ml;   Drug: Triamcinolone 10 mg/ml;   Drug: Intralesional Saline
16 Unknown  Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Condition: Alopecia
Intervention: Drug: Clobetasol Propionate 0.05% Emollient Foam
17 Not yet recruiting Safety and Efficacy Study of Hairstetics' ANCHORING SYSTEM For Hair Extensions For Subjects Affected With Hair Thinning
Conditions: Post Radiation/Chemotherapy Alopecia Presents With Hair Thinning.;   Post-burn Alopecia Presents With Hair Thinning.;   Cicatricial Alopecia Presents With Hair Thinning.;   Androgenetic Alopecia Presents With Hair Thinning;   Alopecia Due to Traumatic Injuries Presents With Hair Thinning.;   Alopecia Due to Skin Disease Presents With Hair Thinning.
Intervention: Device: Anchoring system
18 Unknown  Pharmacogenomic Study of Androgenetic Alopecia
Condition: Androgenetic Alopecia
Intervention:
19 Recruiting Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper Deficiency
Conditions: Menkes Disease;   Occipital Horn Syndrome;   Unexplained Copper Deficiency
Intervention: Drug: Copper Histidine
20 Recruiting Scalp Cooling to Prevent Chemo-induced Hair Loss
Conditions: Breast Cancer;   Alopecia
Interventions: Device: PAXMAN Orbis Scalp Cooler;   Other: Control No treatment

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Indicates status has not been verified in more than two years